Outdated Prescription Drug Labeling

Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology

(2016) Angela K. Green et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review

(2015) Bo Wang et al.   BMJ-British Medical Journal

Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review

(2015) Bo Wang et al.   BMJ-British Medical Journal

Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications

(2013) Amy P. Abernethy   ANNALS OF INTERNAL MEDICINE

Off-Label Use of Oncology Drugs: The Need for More Data and Then Some

(2012) David G. Pfister   JOURNAL OF CLINICAL ONCOLOGY

Sources of drug information: FDA-approved labeling and other official FDA sources

(2009) Jill A. Lindstrom   Dermatologic Therapy

U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey

(2009) Donna T. Chen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY